SCHEMBL23319941

SCHEMBL23319941

O=C(O)c1nn[nH]c1Oc1ccc(-n2cccn2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 1/20 0.43
NOTUM Q6P988 1/20 0.39
ICAM1 P05362 1/20 0.39
SELE P16581 1/20 0.39
VCAM1 P19320 1/20 0.39
HDAC4 P56524 1/20 0.39
HAO1 Q9UJM8 9/20 0.38
MGLL Q99685 1/20 0.37
MMP13 P45452 1/20 0.37
MMP14 P50281 1/20 0.37
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23319974 0.84 JAK2 (0.46) KDM4EALDH1A1MAPK1ICAM1SELE
SCHEMBL23484525 0.79 HAO1 (0.55) HAO1
SCHEMBL21296882 0.78 HAO1 (0.44) ALDH1A1HAO1KMT2AMAPT
SCHEMBL23319896 0.77 HAO1 (0.52) HAO1
SCHEMBL21296854 0.76 HAO1 (0.44) KDM4EHDAC4HAO1LMNA
SCHEMBL23319972 0.76 HAO1 (0.51) HAO1
SCHEMBL21296890 0.74 HAO1 (0.52) KDM4EHAO1LMNAMAPT
SCHEMBL21296956 0.74 HAO1 (0.52) HAO1
SCHEMBL21312458 0.74 MCL1 (0.43) ALDH1A1HAO1
SCHEMBL21312442 0.74 GAA (0.45) HAO1MMP13KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
US-20210403439-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS VENTHERA, INC. 2021-12-30 US disclosed
EP-3817816-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS Orfan Biotech Inc. (US) 2021-05-12 EP disclosed
CN-112399873-A Triazole glycolate oxidase inhibitor 奥凡生物科技公司 2021-02-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS XDH, DUOX1, PNPO KDM4E 3502/4885ALDH1A1 262/4885MAPK1 1145/4885
US-20210403439-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS XDH, DUOX1, PNPO KDM4E 3502/4885ALDH1A1 262/4885MAPK1 1145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.